A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients
Giampaolo Morciano,
Gaia Pedriali,
Massimo Bonora,
Rita Pavasini,
Elisa Mikus,
Simone Calvi,
Matteo Bovolenta,
Magdalena Lebiedzinska-Arciszewska,
Mirko Pinotti,
Alberto Albertini,
Mariusz R. Wieckowski,
Carlotta Giorgi,
Roberto Ferrari,
Lorenzo Galluzzi,
Gianluca Campo,
Paolo Pinton
Affiliations
Giampaolo Morciano
Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Ravenna, Italy; Department of Medical Sciences, Section of Experimental Medicine, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, 44121 Ferrara, Italy
Gaia Pedriali
Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Ravenna, Italy
Massimo Bonora
Department of Medical Sciences, Section of Experimental Medicine, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, 44121 Ferrara, Italy
Rita Pavasini
Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, 44121 Ferrara, Italy
Elisa Mikus
Cardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Ravenna, Italy
Simone Calvi
Cardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Ravenna, Italy
Matteo Bovolenta
Genethon, INSERM UMR951, 1 bis, rue de l’Internationale BP60, 91002 Evry Cedex, France
Magdalena Lebiedzinska-Arciszewska
Laboratory of Mitochondrial Biology and Metabolism, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland
Mirko Pinotti
Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy
Alberto Albertini
Cardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Ravenna, Italy
Mariusz R. Wieckowski
Laboratory of Mitochondrial Biology and Metabolism, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland
Carlotta Giorgi
Department of Medical Sciences, Section of Experimental Medicine, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, 44121 Ferrara, Italy
Roberto Ferrari
Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Ravenna, Italy; Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, 44121 Ferrara, Italy
Lorenzo Galluzzi
Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA; Sandra and Edward Meyer Cancer Center, New York, NY, USA; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA; Université de Paris, Paris, France
Gianluca Campo
Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Ravenna, Italy; Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, 44121 Ferrara, Italy
Paolo Pinton
Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Ravenna, Italy; Department of Medical Sciences, Section of Experimental Medicine, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, 44121 Ferrara, Italy; Corresponding author
Summary: Preclinical models of ischemia/reperfusion injury (RI) demonstrate the deleterious effects of permeability transition pore complex (PTPC) opening in the first minutes upon revascularization of the occluded vessel. The ATP synthase c subunit (Csub) influences PTPC activity in cells, thus impacting tissue injury. A conserved glycine-rich domain in Csub is classified as critical because, when mutated, it modifies ATP synthase properties, protein interaction with the mitochondrial calcium (Ca2+) uniporter complex, and the conductance of the PTPC. Here, we document the role of a naturally occurring mutation in the Csub-encoding ATP5G1 gene at the G87 position found in two ST-segment elevation myocardial infarction (STEMI) patients and how PTPC opening is related to RI in patients affected by the same disease. We report a link between the expression of ATP5G1G87E and the response to hypoxia/reoxygenation of human cardiomyocytes, which worsen when compared to those expressing the wild-type protein, and a positive correlation between PTPC and RI.